Marco Anelli, MD | Authors | Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.
The finalists for the 2026 CPHI Pharma Awards span15 categories including API development, digital transformation, ...
In part 1 of this 2-part preview of AAPS PharmSci 360’s keynote on predictive drug development, Robert Holt, PhD, associate ...
David S. Thompson, CSAP, is Chief Alliance Officer at Eli Lilly and Company.
In August 2026, Heidi Overton was nominated for FDA commission, and a wave of oncology and neuro drugs were approved. In ...
On August 31, 2026, Eli Lilly announced it has entered a definitive agreement to acquire Merida Biosciences, a biotechnology ...
The FDA cleared four notable therapies within the same week in late August, spanning infectious disease, cardiometabolic care ...
In part 2 of his overview on hold times in biopharmaceuticals, Robert Dream details the regulations that govern hold times ...
This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...
In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results